Enkephalin, Ala(2)-MePhe(4)-Gly(5)- / pharmacology * Male * Narcotic Antagonists / pharmacology ... MePhe(4)-Gly(5)- * Somatostatin Grants and funding * GM-58905/GM/NIGMS NIH HHS/United States ... enkephalin (DAMGO) and a mu specific antagonist, D-Phe-Cys-Trp-Arg-Thr-Pen-Thr-NH2 (CTAP) on cardiovascular responses in ... enkephalin (DAMGO) and a mu specific ant … ...
Enkephalin, Ala(2)-MePhe(4)-Gly(5)- Grants and funding * Australian Postgraduate Award/International ... MePhe(4)-Gly(5)- / pharmacology * Periaqueductal Gray* * Rats * Rats, Sprague-Dawley ...
... enkephalins MeSH D12.776.641.650.575.281.075 - enkephalin, ala(2)-mephe(4)-gly(5)- MeSH D12.776.641.650.575.281.231 - ... enkephalin, leucine MeSH D12.776.641.650.575.281.381 - enkephalin, methionine MeSH D12.776.641.650.575.281.600 - enkephalin, d- ... 5)- MeSH D12.776.641.650.800.354 - eledoisin MeSH D12.776.641.650.800.475 - kassinin MeSH D12.776.641.650.800.500 - neurokinin ...
Bailey CP, Oldfield S, Llorente J, Caunt CJ, Teschemacher AG, Roberts L et al. Involvement of PKCα and G-protein-coupled ... MePhe(4)-Gly(5)-enkephalin Medicine & Life Sciences 46% * Neurons Medicine & Life Sciences 39% ... Bailey, Christopher P ; Oldfield, S ; Llorente, J et al. / Involvement of PKCα and G-protein-coupled receptor kinase 2 in ... J et al. In: British Journal of Pharmacology, Vol. 158, No. 1, 09.2009, p. 157-164.. Research output: Contribution to journal ...
ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-. ALA(2)-MEPHE(4)-GLY(5)-ENCEFALINA. ... ENKEPHALIN, D-PENICILLAMINE (2,5)-. D-PENICILINA (2,5)-ENCEFALINA. ENCEFALITIS LIMBICA. LIMBIC ENCEPHALITIS. ENCEFALITE LÍMBICA ... FATOR 2 DE ELONGAÇÃO DE PEPTÍDIOS. FACTOR 2 LIBERADOR DE GUANINA NUCLEOTIDO. GUANINE NUCLEOTIDE-RELEASING FACTOR 2. FATOR 2 DE ... FACTOR 2 DE ELONGACION PEPTIDA. PEPTIDE ELONGATION FACTOR 2. ...
ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-. ALA(2)-MEPHE(4)-GLY(5)-ENCEFALINA. ... ENKEPHALIN, D-PENICILLAMINE (2,5)-. D-PENICILINA (2,5)-ENCEFALINA. ENCEFALITIS LIMBICA. LIMBIC ENCEPHALITIS. ENCEFALITE LÍMBICA ... FATOR 2 DE ELONGAÇÃO DE PEPTÍDIOS. FACTOR 2 LIBERADOR DE GUANINA NUCLEOTIDO. GUANINE NUCLEOTIDE-RELEASING FACTOR 2. FATOR 2 DE ... FACTOR 2 DE ELONGACION PEPTIDA. PEPTIDE ELONGATION FACTOR 2. ...
ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-. ALA(2)-MEPHE(4)-GLY(5)-ENCEFALINA. ... ENKEPHALIN, D-PENICILLAMINE (2,5)-. D-PENICILINA (2,5)-ENCEFALINA. ENCEFALITIS LIMBICA. LIMBIC ENCEPHALITIS. ENCEFALITE LÍMBICA ... FATOR 2 DE ELONGAÇÃO DE PEPTÍDIOS. FACTOR 2 LIBERADOR DE GUANINA NUCLEOTIDO. GUANINE NUCLEOTIDE-RELEASING FACTOR 2. FATOR 2 DE ... FACTOR 2 DE ELONGACION PEPTIDA. PEPTIDE ELONGATION FACTOR 2. ...
ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)- ENCEFALINA ALA(2)-MEFE(4)-GLI(5) ALA(2)-MEPHE(4)-GLY(5)-ENCEFALINA ... ENKEPHALIN, D-PENICILLAMINE (2,5)- ENCEFALINA D-PENICILAMINA (2,5) D-PENICILINA (2,5)-ENCEFALINA ... FACTOR 2 DE ELONGACION PEPTIDA FATOR 2 DE ELONGAÇÃO DE PEPTÍDIOS PEPTIDE ELONGATION FACTOR G FACTOR G DE ELONGACION PEPTIDA ... GUANINE NUCLEOTIDE-RELEASING FACTOR 2 FACTOR 2 LIBERADOR DE GUANINA NUCLEOTIDO FATOR 2 DE LIBERAÇÃO DO NUCLEOTÍDIO GUANINA ...
ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)- ENCEFALINA ALA(2)-MEFE(4)-GLI(5) ALA(2)-MEPHE(4)-GLY(5)-ENCEFALINA ... ENKEPHALIN, D-PENICILLAMINE (2,5)- ENCEFALINA D-PENICILAMINA (2,5) D-PENICILINA (2,5)-ENCEFALINA ... FACTOR 2 DE ELONGACION PEPTIDA FATOR 2 DE ELONGAÇÃO DE PEPTÍDIOS PEPTIDE ELONGATION FACTOR G FACTOR G DE ELONGACION PEPTIDA ... GUANINE NUCLEOTIDE-RELEASING FACTOR 2 FACTOR 2 LIBERADOR DE GUANINA NUCLEOTIDO FATOR 2 DE LIBERAÇÃO DO NUCLEOTÍDIO GUANINA ...
ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)- ENCEFALINA ALA(2)-MEFE(4)-GLI(5) ... MEPHE(4)-GLY(5)-ENCEFALINA ... FATOR 2 DE ELONGAÇÃO DE PEPTÍDIOS PEPTIDE ELONGATION FACTOR 2 ... FACTOR 2 DE ELONGACION PEPTIDA FATOR 2 DE LIBERAÇÃO DO NUCLEOTÍDIO GUANINA GUANINE NUCLEOTIDE-RELEASING FACTOR 2 FACTOR 2 ... D-PENICILINA (2,5)-ENCEFALINA ENKEPHALIN, D-PENICILLAMINE (2,5)- ENCEFALINA D-PENICILAMINA (2,5) ...
ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-. ALA(2)-MEPHE(4)-GLY(5)-ENCEFALINA. ... ENKEPHALIN, D-PENICILLAMINE (2,5)-. D-PENICILINA (2,5)-ENCEFALINA. ENCEFALITIS LIMBICA. LIMBIC ENCEPHALITIS. ENCEFALITE LÍMBICA ... FATOR 2 DE ELONGAÇÃO DE PEPTÍDIOS. FACTOR 2 LIBERADOR DE GUANINA NUCLEOTIDO. GUANINE NUCLEOTIDE-RELEASING FACTOR 2. FATOR 2 DE ... FACTOR 2 DE ELONGACION PEPTIDA. PEPTIDE ELONGATION FACTOR 2. ...
ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)- ENCEFALINA ALA(2)-MEFE(4)-GLI(5) ALA(2)-MEPHE(4)-GLY(5)-ENCEFALINA ... ENKEPHALIN, D-PENICILLAMINE (2,5)- ENCEFALINA D-PENICILAMINA (2,5) D-PENICILINA (2,5)-ENCEFALINA ... FACTOR 2 DE ELONGACION PEPTIDA FATOR 2 DE ELONGAÇÃO DE PEPTÍDIOS PEPTIDE ELONGATION FACTOR G FACTOR G DE ELONGACION PEPTIDA ... GUANINE NUCLEOTIDE-RELEASING FACTOR 2 FACTOR 2 LIBERADOR DE GUANINA NUCLEOTIDO FATOR 2 DE LIBERAÇÃO DO NUCLEOTÍDIO GUANINA ...
ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)- ENCEFALINA ALA(2)-MEFE(4)-GLI(5) ... MEPHE(4)-GLY(5)-ENCEFALINA ... FATOR 2 DE ELONGAÇÃO DE PEPTÍDIOS PEPTIDE ELONGATION FACTOR 2 ... FACTOR 2 DE ELONGACION PEPTIDA FATOR 2 DE LIBERAÇÃO DO NUCLEOTÍDIO GUANINA GUANINE NUCLEOTIDE-RELEASING FACTOR 2 FACTOR 2 ... D-PENICILINA (2,5)-ENCEFALINA ENKEPHALIN, D-PENICILLAMINE (2,5)- ENCEFALINA D-PENICILAMINA (2,5) ...
ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)- ENCEFALINA ALA(2)-MEFE(4)-GLI(5) ALA(2)-MEPHE(4)-GLY(5)-ENCEFALINA ... ENKEPHALIN, D-PENICILLAMINE (2,5)- ENCEFALINA D-PENICILAMINA (2,5) D-PENICILINA (2,5)-ENCEFALINA ... FACTOR 2 DE ELONGACION PEPTIDA FATOR 2 DE ELONGAÇÃO DE PEPTÍDIOS PEPTIDE ELONGATION FACTOR G FACTOR G DE ELONGACION PEPTIDA ... GUANINE NUCLEOTIDE-RELEASING FACTOR 2 FACTOR 2 LIBERADOR DE GUANINA NUCLEOTIDO FATOR 2 DE LIBERAÇÃO DO NUCLEOTÍDIO GUANINA ...
ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)- ENCEFALINA ALA(2)-MEFE(4)-GLI(5) ALA(2)-MEPHE(4)-GLY(5)-ENCEFALINA ... ENKEPHALIN, D-PENICILLAMINE (2,5)- ENCEFALINA D-PENICILAMINA (2,5) D-PENICILINA (2,5)-ENCEFALINA ... FACTOR 2 DE ELONGACION PEPTIDA FATOR 2 DE ELONGAÇÃO DE PEPTÍDIOS PEPTIDE ELONGATION FACTOR G FACTOR G DE ELONGACION PEPTIDA ... GUANINE NUCLEOTIDE-RELEASING FACTOR 2 FACTOR 2 LIBERADOR DE GUANINA NUCLEOTIDO FATOR 2 DE LIBERAÇÃO DO NUCLEOTÍDIO GUANINA ...
ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)- ENCEFALINA ALA(2)-MEFE(4)-GLI(5) ... MEPHE(4)-GLY(5)-ENCEFALINA ... FATOR 2 DE ELONGAÇÃO DE PEPTÍDIOS PEPTIDE ELONGATION FACTOR 2 ... FACTOR 2 DE ELONGACION PEPTIDA FATOR 2 DE LIBERAÇÃO DO NUCLEOTÍDIO GUANINA GUANINE NUCLEOTIDE-RELEASING FACTOR 2 FACTOR 2 ... D-PENICILINA (2,5)-ENCEFALINA ENKEPHALIN, D-PENICILLAMINE (2,5)- ENCEFALINA D-PENICILAMINA (2,5) ...
DAGO ([D-Ala2,N-Me-Phe4,Gly-ol5]-enkephalin), a specific μ agonist, evoked a significant dose-dependent (10-7-10-5 M) ... DAGO ([D-Ala2,N-Me-Phe4,Gly-ol5]-enkephalin), a specific μ agonist, evoked a significant dose-dependent (10-7-10-5 M) ... MePhe(4)-Gly(5)-enkephalin Medicine & Life Sciences 60% * Opioid Analgesics Medicine & Life Sciences 43% ... DAGO ([D-Ala2,N-Me-Phe4,Gly-ol5]-enkephalin), a specific μ agonist, evoked a significant dose-dependent (10-7-10-5 M) ...
This presynaptic inhibitory action was mimicked by [D-Ala2, N-Me-Phe4, Gly5-ol]-enkephalin (0.1 μM) and the analgesic dipeptide ... This presynaptic inhibitory action was mimicked by [D-Ala2, N-Me-Phe4, Gly5-ol]-enkephalin (0.1 μM) and the analgesic dipeptide ... This presynaptic inhibitory action was mimicked by [D-Ala2, N-Me-Phe4, Gly5-ol]-enkephalin (0.1 μM) and the analgesic dipeptide ... This presynaptic inhibitory action was mimicked by [D-Ala2, N-Me-Phe4, Gly5-ol]-enkephalin (0.1 μM) and the analgesic dipeptide ...
The μ-opioid receptor (MOP-R) agonist [D-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin (DAMGO) also produced dose-dependent flexor ... The μ-opioid receptor (MOP-R) agonist [D-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin (DAMGO) also produced dose-dependent flexor ... Ono, Takeshi ; Inoue, Makoto ; Harunor Rashid, M. et al. / Stimulation of peripheral nociceptor endings by low dose morphine ... The μ-opioid receptor (MOP-R) agonist [D-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin (DAMGO) also produced dose-dependent flexor ...
Ko, M. C.Holden ; Song, M. S. ; Edwards, T. et al. / The role of central μ opioid receptors in opioid-induced itch in primates ... Intrathecal (i.t.) administration of peptidic MOR agonist [D-Ala2, N-Me-Phe 4,Gly5-ol]-enkephalin (DAMGO, 0.00032-0.01 mg) ... Gly5-ol]-enkephalin (DAMGO, 0.00032-0.01 mg) evoked scratching, but i.v, DAMGO (0.01-1 mg/kg) did not increase scratching. A ... enkephalin (DAMGO, 0.00032-0.01 mg) evoked scratching, but i.v, DAMGO (0.01-1 mg/kg) did not increase scratching. A similar ...
intra-nac treatment with the selective μ-opioid receptor agonist [d-ala(2),n-mephe(4),gly(5)-ol]enkephalin (damgo) (0.1-10 ng) ... intra-nac treatment with β-endorphin (0.01-1 μg) increased social play, but met-enkephalin (0.1-5 μg) and the enkephalinase ... enkephalin) (0.3-3 μg) had no effects, whereas the κ-opioid receptor agonist u69593 (n-methyl-2-phenyl-n-[(5r,7s,8s)-7-( ... simon et al 1979) and certainly spare the rewarding effects of apomorphine (roberts & vickers 1988). it is clear that reward ...
Microinjection of the µ receptor agonist [D-Ala(2) , MePhe(4) , Gly(5) -ol]-enkephalin (DAMGO), but not that of the α2A - ... BACKGROUND AND PURPOSE: µ-Opioid receptors, pro-opiomelanocortin and pro-enkephalin are highly expressed in the nucleus tractus ... MePhe(4)-Gly(5)-Encefalina/administração & dosagem , Ala(2)-MePhe(4)-Gly(5)-Encefalina/farmacologia , Hipertensão/induzido ... 2. Use of fibrates is not associated with reduced risks of mortality or cardiovascular events among ESRD patients: A national ...
Enkephalin, Ala(2)-MePhe(4)-Gly(5)- D12.776.641.650.575.281.75 D12.776.631.650.575.281.75 Enkephalin, D-Penicillamine (2,5)- ... MePhe(4),Met(0)-ol-enkephalin D12.776.641.650.575.281.381.500 D12.776.631.650.575.281.381.500 Dabigatran D3.438.103.280 D3.633. ... Enkephalin, Methionine D12.776.641.650.575.281.381 D12.776.631.650.575.281.381 Enkephalins D12.776.641.650.575.281 D12.776. ... D12.776.641.650.575.281.600 D12.776.631.650.575.281.600 Enkephalin, Leucine D12.776.641.650.575.281.231 D12.776.631.650.575.281 ...
... d-Ala(2),N-MePhe(4),Gly-ol(5)]enkephalin binding assay was not significantly changed by a deletion of the dopamine D(3) ... The &mgr;-opioid receptor in the brain determined by the [tylosil-3,5-(3)H(N)]-[ ...
D-Ala, MePhe4, Gly-ol5] (DAGO), low levels of kappa opioid receptor binding using the radioligand [3H]-[ethylketocyclazocine] ( ... Leu-enkephalin, and an absence of delta opioid receptor binding with the radioligand [3H]-[D-A1a2, D-Leu5]-enkephalin (DADLE) ... There was no reresponse to changes in pO2 from more than 500 mm. Hg to 59.6 mm. Hg, but when pO2 was lowered below 50 mm. Hg ... It was found that there was no response to changes in pCO2 from 38.1 mm. Hg to 26.6 mm. Hg. but there was some constriction of ...
... enkephalin) nor the μ-opioid agonist, DAMGO (Tyr-D-Ala-Gly-N-Me-Phe-Gly-ol enkephalin) elevated [Ca2+](i) when applied alone. ... enkephalin) nor the μ-opioid agonist, DAMGO (Tyr-D-Ala-Gly-N-Me-Phe-Gly-ol enkephalin) elevated [Ca2+](i) when applied alone. ... enkephalin) nor the μ-opioid agonist, DAMGO (Tyr-D-Ala-Gly-N-Me-Phe-Gly-ol enkephalin) elevated [Ca2+](i) when applied alone. ... enkephalin) nor the μ-opioid agonist, DAMGO (Tyr-D-Ala-Gly-N-Me-Phe-Gly-ol enkephalin) elevated [Ca2+](i) when applied alone. ...
Analgesics, Opioid; Animals; Calcium; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Male; Pituitary Gland, Posterior; Presynaptic ... N-Me-Phe(4),Gly5-ol]-Enkephalin (DAMGO), a MOR agonist, that is blocked by D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP), a ... 2014 Mar 5;34(10):3733-42. doi: 10.1523/JNEUROSCI.2505-13.2014. Link to article on publishers site ...
Yong Q-C, Cheong JL, Hua F, Deng L-W, Khoo YM, Lee H-S, Perry A, Wood M, Whiteman M, Bian J-S, et al (2011). Regulation of ... N-Me-Phe(4),Gly(5)-ol]-Enkephalin, a selective μ-opioid receptor agonist. Blockade of extracellular-regulated protein kinase 1/ ... Gly(5)-ol]-Enkephalin, a selective μ-opioid receptor agonist. Blockade of extracellular-regulated protein kinase 1/2 (ERK1/2) ... Yong Q-C, Cheong JL, Hua F, Deng L-W, Khoo YM, Lee H-S, Perry A, Wood M, Whiteman M, Bian J-S, et al (2011). Regulation of ...
... d-Ala-Gly-MePhe-Glyol (DAMGO) were generously donated by the National Institute on Drug Abuse (NIDA; Bethesda, MD). Idazoxan ... A, Met-enkephalin (ME, 30 μm, indicated bybar under trace) hyperpolarized the neuron (from −71 mV, −30 pA applied current; ... Andrade et al., 1983; Christie et al., 1987), but a small (0.6 Hz,Kogan et al., 1992) excitation, representing only a fraction ... Andrade et al., 1983; Christie et al., 1987; Wimpey et al., 1989; Kennedy and Henderson, 1991, 1992). For example, although ...
Enkephalin, Enkephalins/administration & dosage/*pharmacology, Gordon T L, Hoskins D L, Inbred F344, Injections, Male, Pain/* ... Substance P (SP) levels in the spinal cords of very old rats are less than the levels in younger rats (Bergman et al., 1996). ... Gly(5)-, Analgesics, Animals, Chinrock K M, Crisp T, D-Penicillamine (2, Dayal B, delta/agonists, Dose-Response Relationship, ... MePhe(4)-Gly(5)-, Analgesics/*pharmacology, Analysis of Variance, Animals, beta-Endorphin/administration & dosage/*pharmacology ...